Next Issue
Volume 164, 01
Previous Issue
Volume 164, 01
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
SANPP
Volume 164
Issue 2
share announcement
Swiss Archives of Neurology, Psychiatry and Psychotherapy is published by MDPI from Volume 176 Issue 1 (2026). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the previous journal publisher.

Swiss Arch. Neurol. Psychiatry Psychother., Volume 164, Issue 2 (01 2013) – 4 articles , Pages 45-69

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
165 KB  
Review
Anorexia nervosa, Bulimia nervosa und andere Essstörungen im Kindes- und Jugendalter
by Dagmar Pauli
Swiss Arch. Neurol. Psychiatry Psychother. 2013, 164(2), 59-69; https://doi.org/10.4414/sanp.2013.00128 - 1 Jan 2013
Cited by 3 | Viewed by 34
Abstract
Anorexia nervosa, bulimia nervosa and other eating disorders in childhood and adolescence. Review and recommendations on diagnosis and treatment. The diagnosis and treatment of eating disorders in childhood and adolescence demands specific knowledge of the particular features of symptomatology and approaches [...] Read more.
Anorexia nervosa, bulimia nervosa and other eating disorders in childhood and adolescence. Review and recommendations on diagnosis and treatment. The diagnosis and treatment of eating disorders in childhood and adolescence demands specific knowledge of the particular features of symptomatology and approaches in this age group. The diagnostic criteria in the handbooks are only conditionally valid in young patients and their application must be adapted to the patient’s age. Clinically relevant atypical eating disorders have a prevalence similar to the classic forms of anorexia nervosa or bulimia nervosa. High rates of comorbidity exist, in particular with anxiety states and also depression. Monitoring of concomitant somatic symptoms is indispensable. Early detection and treatment improve prognosis. Treatment is multidisciplinary and multimodal. Transdiagnostic approaches take into account the high migration rate of eating disorder diagnoses. There is evidence for the efficacy of family-based therapy in adolescents with anorexia nervosa. In individual psychotherapy motivational treatment, and in bulimia nervosa cognitive behavioural therapy, are in the forefront. Fluoxetine has proved effective in the treatment of binge eating in bulimia nervosa. Full article
►▼ Show Figures

Figure 1

156 KB  
Review
Osteoporose: Auch ein Thema in der Neurologie?
by Daniel Eschle and André G. Aeschlimann
Swiss Arch. Neurol. Psychiatry Psychother. 2013, 164(2), 47-54; https://doi.org/10.4414/sanp.2013.00126 - 1 Jan 2013
Cited by 1 | Viewed by 36
Abstract
This review introduces neurologists to the salient features of osteoporosis risk assessment and treatment. Osteoporosis is a form of progressive bone fragility, which in turn leads to an increased risk of fractures (even after minor trauma). Apart from old age and postmenopausal status, [...] Read more.
This review introduces neurologists to the salient features of osteoporosis risk assessment and treatment. Osteoporosis is a form of progressive bone fragility, which in turn leads to an increased risk of fractures (even after minor trauma). Apart from old age and postmenopausal status, a number of additional risk factors for osteoporotic (fragility) fractures have been identified. These risk factors are particularly common among patients with chronic neurologic disease, for example due to decreased mobility (in combination with an increased risk of falls), and the detrimental effects of long-term medication with steroids or anti-epileptic drugs. A key element in preventing falls and fractures is an adequate level of vitamin D (which may also be useful in preventing multiple sclerosis). Patients who have suffered a fragility fracture need additional medication to prevent further bone loss. The various drugs that can be used for this purpose and the Swiss prescribing restrictions are discussed. Full article
►▼ Show Figures

Figure 1

26 KB  
Editorial
Essen und Trinken als Krankheiten
by Karl Studer
Swiss Arch. Neurol. Psychiatry Psychother. 2013, 164(2), 46; https://doi.org/10.4414/sanp.2013.00145 - 1 Jan 2013
Viewed by 28
Abstract
In der Waadt, einem Land der Lebensfreude, besteht auch eine alte Tradition des Umgangs mit Sucht und Abhängigkeiten [...] Full article
32 KB  
Editorial
Osteoporose in der neurologischen Praxis
by Christian W. Hess
Swiss Arch. Neurol. Psychiatry Psychother. 2013, 164(2), 45; https://doi.org/10.4414/sanp.2013.00146 - 1 Jan 2013
Viewed by 32
Abstract
Die Langzeitbetreuung chronisch-neurologischer Patienten gehört zunehmend zu den vornehmen [...] Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Previous Issue
Next Issue
Back to TopTop